Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

Imaging characteristics of intramuscular myxomas on F-18 FDG PET/CT.

Brendan Lunn and Stephen Broski
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 123;
Brendan Lunn
1Mayo Clinic Rochester MN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Broski
1Mayo Clinic Rochester MN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 58 no. supplement 1 123

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2017.

Copyright & Usage 
© 2017

Author Information

  1. Brendan Lunn1 and
  2. Stephen Broski1
  1. 1Mayo Clinic Rochester MN United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2017 to April 2025

AbstractFullPdf
May 2017200
Jun 20172200
Jul 20171200
Aug 2017500
Sep 2017200
Oct 2017800
Nov 20171000
Dec 2017400
Jan 2018100
Feb 2018400
Mar 2018300
Apr 2018800
May 20181000
Jun 2018100
Jul 2018100
Aug 2018200
Sep 2018200
Oct 2018500
Nov 2018600
Dec 2018500
Jan 2019400
Feb 2019300
Mar 20191000
Apr 2019600
May 2019300
Jun 2019200
Jul 2019300
Aug 2019300
Sep 2019200
Oct 2019200
Nov 2019300
Dec 2019400
Jan 2020400
Feb 2020600
Mar 20201900
Apr 20201000
May 2020400
Jun 2020500
Jul 2020400
Aug 20201500
Sep 20202300
Oct 20201800
Nov 20202300
Dec 20201100
Jan 2021700
Feb 2021800
Mar 20211000
Apr 2021700
May 20211000
Jun 2021400
Jul 20212100
Aug 20213100
Sep 20211400
Oct 20211200
Nov 20217300
Dec 20214300
Jan 20226400
Feb 20222500
Mar 20222200
Apr 20221500
May 20222100
Jun 2022800
Jul 2022500
Aug 2022700
Sep 20221300
Oct 2022900
Nov 2022900
Dec 2022500
Jan 2023900
Feb 20231000
Mar 20231500
Apr 20231100
May 20231600
Jun 20231500
Jul 2023700
Aug 2023800
Sep 2023500
Oct 20231100
Nov 2023900
Dec 2023500
Jan 20241000
Feb 2024200
Mar 20241400
Apr 2024700
May 2024900
Jun 2024100
Jul 2024900
Aug 20241200
Sep 20241600
Oct 20241000
Nov 20241500
Dec 2024600
Jan 20251500
Feb 2025900
Mar 20251300
Apr 20251100
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Imaging characteristics of intramuscular myxomas on F-18 FDG PET/CT.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Imaging characteristics of intramuscular myxomas on F-18 FDG PET/CT.
Brendan Lunn, Stephen Broski
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 123;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Imaging characteristics of intramuscular myxomas on F-18 FDG PET/CT.
Brendan Lunn, Stephen Broski
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 123;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Proton Range Verification with PET Imaging in Brain and Head and Neck Cancers
Show more Oncology, Clinical Diagnosis Track

Other Tumors

  • CLINICAL IMPACT OF FDG PET CT IN THE MANAGEMENT OF CANCER PATIENTS. EXPERIENCE IN 7700 CASES
  • F-18 FDG PET/CT in patients with adrenocortical carcinoma- A tertiary care centre experience
  • Does 18F-FDG PET/CT have an additive role in evaluation of childhood Langerhans Cell Histiocytosis?
Show more Other Tumors

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire